Denise L. Blomquist - 17 Mar 2025 Form 3 Insider Report for Medtronic plc (MDT)

Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Issuer symbol
MDT
Transactions as of
17 Mar 2025
Net transactions value
$0
Form type
3
Filing time
26 Mar 2025, 16:18:03 UTC
Next filing
30 Apr 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MDT Ordinary Shares 7,416 17 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MDT Stock Option (Right to Buy) 17 Mar 2025 Ordinary Shares 214 $78.00 Direct F2
holding MDT Stock Option (Right to Buy) 17 Mar 2025 Ordinary Shares 351 $88.06 Direct F2
holding MDT Stock Option (Right to Buy) 17 Mar 2025 Ordinary Shares 1,102 $83.97 Direct F2
holding MDT Stock Option (Right to Buy) 17 Mar 2025 Ordinary Shares 523 $89.08 Direct F2
holding MDT Stock Option (Right to Buy) 17 Mar 2025 Ordinary Shares 2,762 $89.45 Direct F2
holding MDT Stock Option (Right to Buy) 17 Mar 2025 Ordinary Shares 1,884 $103.26 Direct F2
holding MDT Stock Option (Right to Buy) 17 Mar 2025 Ordinary Shares 3,306 $97.33 Direct F2
holding MDT Stock Option (Right to Buy) 17 Mar 2025 Ordinary Shares 2,620 $131.26 Direct F2
holding MDT Stock Option (Right to Buy) 17 Mar 2025 Ordinary Shares 3,821 $93.08 Direct F2
holding MDT Stock Option (Right to Buy) 17 Mar 2025 Ordinary Shares 769 $87.34 Direct F2
holding MDT Stock Option (Right to Buy) 17 Mar 2025 Ordinary Shares 4,333 $87.76 Direct F2
holding MDT Performance Share Unit 17 Mar 2025 Ordinary Shares 1,316 Direct F3, F4, F5
holding MDT Performance Share Unit 17 Mar 2025 Ordinary Shares 310 Direct F3, F5, F6
holding MDT Performance Share Unit 17 Mar 2025 Ordinary Shares 1,621 Direct F5, F7, F8
holding MDT Performance Share Unit 17 Mar 2025 Ordinary Shares 1,431 Direct F5, F9, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 651 restricted stock units that vest on August 1, 2025; 395 restricted stock units that vest on January 29, 2026; 649 restricted stock units that vest of July 31, 2026; 395 restricted stock units that vest on January 29, 2027; and 1,431 restricted stock units that vest on July 29, 2027.
F2 These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
F3 The performance share units vest on August 1, 2025.
F4 The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 1,316 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F5 Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F6 The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 310 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F7 The performance share units vest on April 24, 2026.
F8 The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 1,621 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F9 The performance share units vest on April 27, 2027.
F10 The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 1,431 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.